Mattis Gottlow

TL;DR: In patients undergoing hemodialysis, the initiation of treatment with rosuvastatin lowered the LDL cholesterol level but had no significant effect on the composite primary end point of death from cardiovascular causes, nonf fatal myocardial infarction, or nonfatal stroke.

TL;DR: Esomeprazole-based triple therapy is effective for the eradication of H. pylori, healing of GU and prevention of relapse and monotherapy for 3 weeks after triple therapy may be beneficial in terms of healing.

TL;DR: Available data relating to cardiovascular outcomes and the role of statin therapy in patients with CKD, including pre-dialysis, dialysis, and renal transplant patients are described to help guide clinicians in the management of CKD.

TL;DR: Endoscopic abnormalities are common in GU patients and persist after proton-pump inhibitor-based triple therapy for H. pylori eradication, which is associated with large, sustained improvements in histological variables.

TL;DR: This Phase III, randomized, double-blind, parallel-group, placebo-controlled TROPOS study will evaluate the OCS-sparing potential of tralokinumab in patients with severe asthma requiring continuous ICS-LABA and chronic maintenance OCS.